BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
88.81
-0.40 (-0.45%)
Oct 20, 2026, 10:27 AM EDT - Market open
BioNTech SE Employees
BioNTech SE had 7,807 employees as of December 31, 2025. The number of employees increased by 1,035 or 15.28% compared to the previous year. That makes BioNTech SE the 4,052nd largest employer in the world and 898th in the United States.
Employees
7,807
Change (1Y)
1,035
Growth (1Y)
15.28%
Revenue / Employee
$387,797
Profits / Employee
-$246,785
Market Cap
22.31B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 7,807 | 1,035 | 15.28% |
| Dec 31, 2024 | 6,772 | 639 | 10.42% |
| Dec 31, 2023 | 6,133 | 1,603 | 35.39% |
| Dec 31, 2022 | 4,530 | 1,448 | 46.98% |
| Dec 31, 2021 | 3,082 | 1,141 | 58.78% |
| Dec 31, 2020 | 1,941 | 631 | 48.17% |
| Dec 31, 2019 | 1,310 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Genmab | 3,119 |
| Jazz Pharmaceuticals | 2,890 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| Insmed | 1,664 |
| Ascendis Pharma | 1,189 |
| Exelixis | 1,077 |
| BridgeBio Pharma | 1,003 |
BNTX News
- 3 hours ago - BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026 - GlobeNewsWire
- 1 day ago - BioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026 - GlobeNewsWire
- 5 days ago - BioNTech Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into BioNTech (BNTX) - PRNewsWire
- 6 days ago - BioNTech price target lowered to $132 from $136 at Canaccord - TheFly
- 6 days ago - BioNTech cancer vaccine trial PFS miss ‘not surprising,’ says Evercore ISI - TheFly
- 6 days ago - Citi still sees development path for BNT113 despite study miss - TheFly
- 6 days ago - BMO says BioNTech PFS miss adds to mRNA setbacks, shares likely under pressure - TheFly
- 7 days ago - BioNTech reports AHEAD-MERIT trial did not meet first dual primary endpoint - TheFly